The Discounted Cash Flow (DCF) valuation of Britannia Life Sciences Inc (BLAB.CN) is (0.51) CAD. With the latest stock price at 0.07 CAD, the upside of Britannia Life Sciences Inc based on DCF is -832.6%.
Based on the latest price of 0.07 CAD and our DCF valuation, Britannia Life Sciences Inc (BLAB.CN) is a sell. selling BLAB.CN stocks now will result in a potential gain of 832.6%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.3% - 12.6% | 8.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (7.17) - (0.29) | (0.51) |
| Upside | -10348.5% - -517.2% | -832.6% |